跳至主要内容
临床试验/EUCTR2015-004657-40-SE
EUCTR2015-004657-40-SE进行中(未招募)1 期

Minimizing contrast agent in computed tomography pulmonary angiography

Region Örebro län0 个研究点目标入组 55 人开始时间: 2016年4月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
55

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age >= 40 years
  • - Referred for computed tomography concerning thorax/chest-abdomen, or similar
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 55
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 55

排除标准

  • - Referral including question of aortic dissection or aortic aneurysm.
  • - Previous hypersensitivity to iodinized contrast agent, CT-examination planned with prophylaxis against hypersensitivity reaction or clinical request to minimize contrast agent dose.
  • - Previous examination with iodinized contrast agent within the last 48 hours.
  • - CT-protocol selection for clinical series not suitable for combination with study protocol.
  • - Contrast agent dose for clinical series > 100 ml, or not suitable for combination with study protocol.
  • - Patient weight >85 kg.
  • - Estimated Glomerular Filtration Rate <60 ml/min.
  • - Serum or plasma creatinine test older than 24 hours (acute referral) / older than 3 months (non-acute referral/planned examinations).
  • - Patient requiring continous medical surveillance.
  • - Patient requiring interpreter or inable to follow breathing instructions for examination.
  • - Pregnant, potentially pregnant or nursing women, according to the patient.
  • - Patient unable to perform CT-examination with arms above the head or patient without periferal venous catheter in the arm.
  • - Thyrotoxicosis or Myastenia gravis

研究者

相似试验